SSKN Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

7.80M

-18.71%

-0.400

-66.1%

7.42M

+8.9%

-0.395

-31.9%

8.76M

+14.32%

-0.210

-65%

Estimates Revision

The market is revising Upward the revenue expectations for STRATA Skin Sciences, Inc. (SSKN) for FY2025, with the revenue forecasts being adjusted by 2.35% over the past three months. During the same period, the stock price has changed by -24.10%.

Revenue Estimates for FY2025

Revise Upward

+2.35%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-2.88%

In Past 3 Month

Stock Price

Go Down

-24.10%

In Past 3 Month

1 Analyst Rating

Wall Street analysts forecast SSKN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SSKN is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

4.00

Averages

4.00

High

4.00

Current: 0.000

Low

4.00

Averages

4.00

High

4.00

Maxim Group

Anthony Vendetti

Strong Buy

Initiates

2025-02-27

Reason

Maxim Group

Anthony Vendetti

Price Target

2025-02-27

Initiates

Strong Buy

Reason

Valuation Metrics

The current forward P/E ratio for Strata Skin Sciences Inc (SSKN.O) is -0.85, compared to its 5-year average forward P/E of -6.52. For a more detailed relative valuation and DCF analysis to assess Strata Skin Sciences Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-6.52

Current PE

-0.85

Overvalued PE

-1.01

Undervalued PE

-12.03

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-0.30

Current EV/EBITDA

-30.58

Overvalued EV/EBITDA

33.64

Undervalued EV/EBITDA

-34.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.86

Current PS

0.24

Overvalued PS

1.42

Undervalued PS

0.30

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

SSKN News & Events

Events Timeline

No data

News

3.5

2025-12-09Globenewswire

STRATA Showcases New Technologies at 2025 Dermatology Congress, Anticipates 12 New Clients in Mexico

9.5

2025-10-29Benzinga

Teradyne Shares Surge Over 20%; Check Out 20 Stocks Making Moves in Premarket Trading

9.0

2025-10-29Benzinga

STRATA Skin Sciences Sees 25% Pre-Market Increase — Find Out the Reasons

People Also Watch

Frequently Asked Questions

What is Strata Skin Sciences Inc (SSKN) stock price today?

The current price of SSKN is 1.313 USD — it has decreased -2.01 % in the last trading day.

What is Strata Skin Sciences Inc (SSKN)'s business?

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

What is the price predicton of SSKN Stock?

What is Strata Skin Sciences Inc (SSKN)'s revenue for the last quarter?

Strata Skin Sciences Inc revenue for the last quarter amounts to 6.93M USD, decreased -21.23 % YoY.

What is Strata Skin Sciences Inc (SSKN)'s earnings per share (EPS) for the last quarter?

Strata Skin Sciences Inc. EPS for the last quarter amounts to -0.36 USD, decreased -29.41 % YoY.

What changes have occurred in the market's expectations for Strata Skin Sciences Inc (SSKN)'s fundamentals?

How many employees does Strata Skin Sciences Inc (SSKN). have?

Strata Skin Sciences Inc (SSKN) has 106 emplpoyees as of January 10 2026.

What is Strata Skin Sciences Inc (SSKN) market cap?

Today SSKN has the market capitalization of 7.73M USD.